Industry has welcomed the launch of the Global AMR Action Fund , which aims to bring two to four new antibiotics to patients by 2030 to tackle antimicrobial resistance (AMR). The AMR Action Fund was launched on July 9, 2020.
More than 20 biopharmaceutical companies are involved in the f
